Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2899_Библиотеки_им_академика_М_И_Перельмана
.pdf
•
•
•
•
•
•
1.
2.
3.
4.
5.
Acutemanagement
Riskassessment
Involving the MDT, formulate a risk management plan based on your risk assessment.
Takeintoaccountadvanceddirectivesandconsiderwhatmeasuresandapproacheshave
helpedinthepast.
De-escalation
Takethefollowingapproachwithpatientsatriskofaggressionorviolence:
Separateagitatedpatientsfromotherswheresafetodoso.Useadesignatedquietareaoftheward
forthisifpossible
Onestaffmembershouldtaketheprimaryroleincommunicatingwiththepatient,butdonotisolate
asinglestaffmemberwiththepatient
Seekclarificationfromthepatient
Negotiatetoresolvethesituationnon-confrontationally
Bemindfulofyourownnon-verbalcommunication(avoidexpressinganxietyorfrustration—tryto
appearcalm)
ConsiderofferingPRNmedications(e.g.promethazine25–50mgPOorlorazepam1–2mgPO).
Restraint
Only use restrictive interventions (e.g. seclusion, restraint) if the above-listed measures
failandthereisariskof harm tothepatientorothersifthisactionisnottaken.Ensure
thatrestrictiveinterventionsare:
Proportionatetothelevelofrisk
Theleastrestrictiveoption
Usedfortheshortestpossibleduration
Usedinaccordancewiththepatient’spreferencesifpossible
Appropriatetothepatient’sdevelopmentalage,physicalhealth,andfrailty.
Mechanical restraint (e.g. handcuffs) should only beused in high-securitysettings, and
onlyasanoptionoflastresort.
Seclusion
Seclusion means confining a patient within a room for the protection of others. If
necessary,itshouldtakeplacewithinadesignatedroom,andthepatientshouldbeunder
continuous observation. It should take place for the shortest duration possible and
reviewsshouldtakeplaceatleastevery2hourstoconsiderwhethertheseclusioncanbe
terminated.
https://t.me/med1917

•
•
•
•
•
Legalstatus
Use of restrictive interventionsshould promptanurgentreview of the patient’s legal
status.Forinformalpatients(voluntaryadmission)whoaresecludedasanemergency,
the need to use powers to detain under the Mental Health Act should be assessed
urgently.
Rapidtranquillization
Thisistheuseofparenteral(usuallyIM)medicationforurgentsedation.
Foradultsuseeitherlorazepam1–2mgIMorhaloperidol5mgIM+promethazine
25–50mgIM.
Whenchoosing,considerthepatient’spreferences,physicalhealthproblems,possible
intoxication, previous response, possible interactions, and total daily dose (including
regularmedications).Ifthereisinsufficientinformation,uselorazepam.
Avoid haloperidol and promethazine if there is no ECG available(risk of dangerous
QTprolongation)orifthereisevidenceofcardiovasculardisease.
Reviewafterthefirstdose.Ifthereisapartialresponse,considergivinganotherdose.
If thereisno response, consider usinganother agent (e.g. if no responseto lorazepam,
thenconsiderhaloperidol/promethazine).
A daily medicationreview bya senior doctor is necessary if the patient is requiring rapid
tranquillization. For patients whodo notrespond torapid tranquillization,geturgent senior
advice.
Followingrapidtranquillization,ensurethatthefollowingaremonitoredatleastevery
hour: pulse, blood pressure, temperature, hydration level, level of consciousness, and
side effects, until there are no further concerns regarding the patient’s physical health.
Theseshouldbemonitoredevery15minutesifanyofthefollowingapply:
DosesofmedicationaregivenexceedingBNFlimits
Thepatientisasleeporsedated
Thepatienthasalsobeenusingdrugsoralcohol
Thepatienthasapre-existingphysicalhealthproblem
Thepatienthasbeenharmedbecauseofarestrictiveintervention.
Treatmentafterstabilization
Pharmacological
Thereshouldbeanagreed‘pharmacologicalstrategy’forpatientsatriskofviolenceand
https://t.me/med1917

•
•
•
•
•
•
•
•
•
•
aggression,includingtheuseofregularandPRNmedication.Thisshouldbeformulated
assoonaspossiblefollowingadmission.
Review this strategy at least once a week. If rapid tranquillization is being used, a
seniordoctorshouldreviewthisatleastonceaday.
Whenreviewingmedication,considerthefollowing:
Whatisthetherapeuticaim?
Howlongshouldthemedicationtaketowork?
Whatisthetotaldoseofmedicationprescribedandadministered,includingPRN?
Haveanydosesbeenmissedandwhy?
Hastherebeenatherapeuticresponse?
Arethereanysideeffects?
WhenprescribingPRNmedication:
Ensurethatthe MDT(particularlynursingstaff)agreeunderwhichcircumstancesthe medication
shouldbeadministered
Ensurethatitisnecessary(PRNmedicationsshouldnotberoutinelyprescribed,althoughtheywill
benecessaryformanypatientswhoareatriskofaggressionandviolence)
CheckthatthetotaldoseofregularandPRNmedicationdoesnotexceedBNFlimits,especiallyif
aregulardailydoseisalsobeingused(BNFmaximumdailydoseforhaloperidolis20mg/day)
ConsiderstoppingPRNmedicationthatisn’tbeingused.Reviewatleastweekly.
DosesabovetheBNFmaximumshouldonlybeprescribedfollowingdiscussionwithasenior
doctor.Clearlydocumenttherationaleforthisdecisioninthepatient’snotesandbeawarethat
thesepatientswillrequireclosermonitoring.
Psychosocial
Consider offering a psychological intervention to enable the patient to develop skills
aimedatreducingtheriskoffutureviolenceandaggression.
Observation
Theobservationlevelisthefrequencywithwhichstaffwillobservethepatienttoensure
theirsafety.AgreethelevelofobservationforeachpatientwiththeMDTaccordingtothe
risk assessment. The following observation levels are usually found on psychiatric
inpatientwards:
https://t.me/med1917

•
•
•
•
Low-levelintermittent(30–60minutes):forlower-riskpatients
High-levelintermittent(15–30minutes):forpatientsat↑butnotimmediaterisk
Continuousobservation(i.e.‘oneto one’):keptateyesight orarm’s lengthofa designatedstaff
member—forpatientswhoareatcontinuousrisk
Multiprofessionalcontinuousobservation(e.g.‘twotoone’):thesepatientsareathighestriskand
requirecontinuousobservationfrommorethanonememberofstaff.
Specialconsiderations
Emergencydepartments
Violence or aggression as symptoms of a known or suspected mental health problem
shouldbemanagedasapsychiatricemergency.Referurgentlytothementalhealthliaison
teamwhoshouldassesswithin1hour.
Furtherreading
1.OgloffJR,DaffernM(2006).Thedynamicappraisalofsituationalaggression:aninstrumenttoassess
riskforimminentaggressioninpsychiatricinpatients.BehavSciLaw.24:799–813.
2.WoodsP,AlmvikR(2002).TheBrosetviolencechecklist(BVC).ActaPsychiatrScand.106:103–5.
https://t.me/med1917

46
47
48
Part7
Nephrology
Acutekidneyinjury
Chronickidneydisease
Hyperkalaemia
https://t.me/med1917

Chapter46
Acutekidneyinjury
Guideline: NICE NG148 (Acute kidney injury: prevention, detection and
management):https://www.nice.org.uk/guidance/ng148
OUPdisclaimer:OxfordUniversity Press makesno representation, express
or implied, that the drugdosagesarecorrectand thatthe recommendations
are an exclusive or mandatory course of care. All health professionals
readingthistexthavearesponsibilitytoevaluateitsappropriatenessandtake
theindividualneedsofthepatientintoaccount.
Localtrustguidelines:pleaserefertoyourlocalguidelinesasnecessary.
Overview
Acutekidneyinjury(AKI)isdefinedasanabrupt(within7days)lossinkidneyfunction,
whichmayoccurinthecontextofpre-existingkidneydiseaseorcompletelynormalrenal
function.
Diagnosis
History/diagnosticcriteria
Factors knowntoprecipitateAKIincludeacuteillness,surgery,and receivingiodinated
contrast. Particular care should be taken in patients with underlying risk factors for
developingAKI,whichinclude:
https://t.me/med1917

•
•
•
•
•
•
•
•
•
•
•
• •
•
•
•
•
CKD
Heartfailure
Liverdisease
Age≥65years
Diabetes
HistoryofAKI
Hypovolaemiaorsepsis
Use of drugs that can cause or exacerbate kidney injury (including diuretics, ACE inhibitors,
ARBs,NSAIDs,andaminoglycosides).
AKIcanbedetectedandstratifiedaccordingtoseverityusingthecriterialistedinTable
46.1.
Table46.1AKIseverityclassificationcriteria(fromRIFLE,AKIN,andKDIGO
systems)
AKI
stage
Serumcreatininecriteria Urineoutputcriteria
1
Creatinineriseof≥26μmol/Lwithin48hoursOR
Creatinineriseof1.5–1.99×baselinewithin7days
Urineoutput<0.5mL/kg/hourfor>6hours(in
adults)
2
Creatinineriseof2–2.99×baselinewithin7days Urineoutput<0.5mL/kg/hourfor>12hours
3
Creatinineriseof3×ormore frombaselinewithin7
daysOR
Creatinineriseto≥354μmol/LOR
Newrequirementforrenalreplacementtherapy
Urineoutput<0.3mL/kg/hourfor>12hours
AKIN,AcuteKidneyInjuryNetwork;KDIGO,KidneyDisease:ImprovingGlobalOutcomes;RIFLE,
Risk,Injury,Failure,Lossofkidneyfunction,andEnd-stagekidneydisease.
AKIitselfwillnotcausesymptomsunlessverysevere.Inthiscase,patientsmaypresentwith
nausea and vomiting, fatigue, shortness of breath (due to pulmonary oedema), peripheral
oedema, and symptoms of uraemia (e.g.itch, chestpaindue to pericarditis, or behavioural
disturbancesduetoencephalopathy).
Examination
AKIexaminationfindingsarelistedinTable46.2.
https://t.me/med1917

•
•
•
•
•
•
•
•
•
Table46.2AKIexaminationfindings
B
Bibasalcoarsecrepitations
C
Coolperipheries
Prolongedcapillaryrefilltime
↑JVP
Tachycardia
D
Drowsiness
E
Pittingoedema
Palpabledistendedbladder
Renalangletenderness
Investigations
InvestigationsthatshouldbecarriedoutinAKIarelistedinTable46.3.
https://t.me/med1917

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Table46.3CausesofAKIandappropriateinvestigations
Type Causes Investigations
Prerenal
(reductionin
bloodsupply
tokidneys)
Dehydration
Sepsis (see
Chapter122)
Shock
ECG
Bloods including FBC, U&E, LFT, bone profile, CRP, blood cultures,
VBG
ChestX-ray
Intrinsic(direct
damageto
kidneys)
Acute
glomerulonephritis
Drugs
Toxins including
iodinatedcontrast
Reduced blood
supply
Pyonephrosis
(infected and
obstructed
kidney)
Myeloma
Rhabdomyolysis
Urinalysis—checkfor(proteinuriaand/orhaematuria)
FBC
Serumelectrophoresis,immunoglobulins,serumfreelightchains
Creatinekinase
Vasculitis screen if blood/protein on urinalysis or otherwise unexplained
AKI (ANCA, complement C3/4, ANA, anti-glomerular basement
membraneantibodies,antistreptolysinOtitres)
Postrenal
(obstructionof
urinaryflow)
Obstructing renal
calculi
Bladder
malignancy
Enlargedprostate
Retroperitoneal
fibrosis
Pelvicmalignancy
Urethralstricture
Ultrasoundofurinarytract
Start with simple investigations to identify a cause before considering performing a vasculitis
screen or electrophoresis/immunoglobulins/serum free light chains, unless there are particular
reasonstosuspectspecificconditions.
Ultrasoundisnotrequiredifthecausehasbeenidentifiedandtreated.
IfthecauseofAKIisnotidentified,considerarenaltractultrasound.
Ifpyonephrosisissuspected,ultrasoundshouldbeperformedwithin6hours.
Management
Themanagementof AKI largelydepends on theunderlyingcause. Callfor helpfroma
senior clinicianif there are anyclinicalconcerns or a high earlywarningsystem score.
https://t.me/med1917

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Generalprinciplesinclude:
Acutemanagement
IVfluids:ifthepatientishypovolaemic
Monitor:U&Eandurineoutput.Urinarycatheterizationmayberequired
Antibiotics:ifsepsisissuspected.Ensurechoiceofantimicrobialagentanddoseareadjustedto
renalfunctionasperlocalguidelines/BNF/RenalDrugDatabase.
Medications review: stop nephrotoxics if indicated and antihypertensives if the patient is
hypotensive. Note that some drugs that are metabolized by the kidney may require dosage
alterationsaccordingtoeGFRorcreatinineclearancetoavoidtoxicity,e.g.digoxin
Renalreplacementtherapy: should beconsideredimmediately ifany ofthe followingare not
respondingtomedicaltherapy:
Hyperkalaemia(seeChapter48)
Metabolicacidosis
Symptomaticuraemia(e.g.tremor,cognitiveimpairment,coma,fits)
Fluidoverload
Pericarditis
Pulmonaryoedema
Anuria.
Treatmentafterstabilization
Referraltotheurologyteamisindicatedincasesofupperurinarytractobstruction.
Refer immediately if suspecting pyonephrosis, obstructed solitary kidney, bilateral
upper urinary tract obstruction, or complications of AKI caused by urological
obstruction. Nephrostomy or stenting should be undertaken as soon as possible, and
within12hoursofdiagnosis.
Referral to the nephrology team is indicated if considering renal replacement
therapy, in patients with a renal transplant, where the cause of AKI is uncertain or if
specialistmanagementofthecauseisneeded.Ifanyofthefollowingarepresent,discuss
withanephrologistassoonaspossible,andwithin24hours:
Adiagnosisrequiringspecialisttreatment(e.g.vasculitis,glomerulonephritis,myeloma)
AKIwithnoclearcause
Inadequateresponsetotreatment
ComplicationsassociatedwithAKI
Stage3AKI
Renaltransplant
Pre-existingCKDstage4or5.
Once the AKI has resolved, consider a referral to nephrology if eGFR remains
<30mL/min/1.73m2.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
